Infection diagnostics in pneumology. Part 1. Survey and methods;Infektionsdiagnostik in der pneumologie. Teil 1. übersicht und methoden

Pneumologie

Volumn 62, Issue 12, 2008, Pages 730-743

  Strassburg, A ^a   Rupp, J ^b   Herth, F J F ^c   Magnussen, H ^d   Zabel, P ^b   Lange, Christoph ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b Medizinische Klinik III am UK SH   (Germany)

^c Abteilung Pneumologie und Beatmungsmedizin   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ARTIFICIAL VENTILATION; BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; INFECTION RISK; LUNG INFECTION; MORTALITY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SPUTUM ANALYSIS; URINALYSIS;

EID: 58149399524     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038235     Document Type: Review

References (125)

1. Lopez AD, Mathers CD, Ezzati M et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757
2. Huntemann I, Lorenzen J. Community acquired pneumonia (CAP). In: Das Kompetenznetz Ambulant Erworbene Pneumonie - CAPNETZ (www.capnetz.de)
3. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180
4. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 Suppl 2: S27-72
5. Hoffken G, Lorenz J, Kern W et al. [S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie 2005; 59: 612-664
6. Lieberman D, Shvartzman P, Korsonsky I et al. Diagnosis of ambulatory community-acquired pneumonia. Comparison of clinical assessment versus chest X-ray. Scand J Prim Health Care 2003; 21: 57-60
7. Wiesbaden SB. Fallpauschalbezogene Krankheitsstatistik (DRG-Statistik), Diagnosen und Prozeduren der vollstationären Patienten und Patientinnen in Krankenhäusern (2006). Fachserie 12 Reihe 6.4, 2007
8. Kothe H, Bauer T, Marre R et al. Outcome of CAP: influence of age, residence status, and antimicrobial treatment. Eur Respir J 2008
9. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416
10. Gastmeier P, Brauer H, Forster D et al. A quality management project in 8 selected hospitals to reduce nosocomial infections: a prospective, controlled study. Infect Control Hosp Epidemiol 2002; 23: 91-97
11. Gastmeier P, Kampf G, Wischnewski N et al. Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998; 38: 37-49
12. Gastmeier P, Geffers C. [Nosocomial infections in Germany. What are the numbers, based on the estimates for 2006?]. Dtsch Med Wochenschr 2008; 133: 1111-1115
13. Nseir S, Di Pompeo C, Soubrier S et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care 2005; 9: R238-245
14. Nseir S, Di Pompeo C, Soubrier S et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005; 128: 1650-1656
15. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29: 2303-2309
16. Cunnion KM, Weber DJ, Broadhead WE et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996; 153: 158-162
17. Fagon JY, Chastre J, Hance AJ et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288
18. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644
19. Fagon JY, Chastre J, Vuagnat A et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275: 866-869
20. Timsit JF, Chevret S, Valcke J et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154: 116-123
21. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993; 270: 1965-1970
22. Craven DE, Kunches LM, Kilinsky V et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133: 792-796
23. Rello J, Ollendorf DA, Oster G et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-2121
24. Leone M, Bourgoin A, Giuly E et al. Influence on outcome of ventilator-associated pneumonia in multiple trauma patients with head trauma treated with selected digestive decontamination. Crit Care Med 2002; 30: 1741-1746
25. Papazian L, Bregeon F, Thirion X et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154: 91-97
26. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996; 153: 343-349
27. Heyland DK, Cook DJ, Griffith L et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256
28. Hyllienmark P, Gardlund B, Persson JO et al. Nosocomial pneumonia in the ICU: a prospective cohort study. Scand J Infect Dis 2007; 39: 676-682
29. Tejerina E, Frutos-Vivar F, Restrepo MI et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006; 21: 56-65
30. Gastmeier P, Sohr D, Geffers C et al. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infektions Surveillance System. Infect Control Hosp Epidemiol 2007; 28: 466-472
31. Rouby JJ, Martin De Lassale E, Poete P et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146: 1059-1066
32. Ferrer M, Esquinas A, Arancibia F et al. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 2003; 168: 70-76
33. Antonelli M, Conti G, Rocco M et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339: 429-435
34. Welte T, Marre R, Suttorp N. What is new in the treatment of community-acquired pneumonia? Med Klin (Munich) 2006; 101: 313-320
35. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994; 96: 313-320
36. Almirall J, Bolibar I, Balanzo X et al. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999; 13: 349-355
37. Hopstaken RM, Muris JW, Knottnerus JA et al. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003; 53: 358-364
38. Hopstaken RM, Butler CC, Muris JW et al. Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice. Fam Pract 2006; 23: 180-187
39. Lim WS, Eerden MM van der, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382
40. Ananda-Rajah MR, Charles PG, Melvani S et al. Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scand J Infect Dis 2007; epub ahead of print: 1-8
41. Bauer TT, Ewig S, Marre R et al. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006; 260: 93-101
42. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250
43. Capelastegui A, Espana PP, Quintana JM et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27: 151-157
44. Aujesky D, Auble TE, Yealy DM et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118: 384-392
45. Pugin J, Auckenthaler R, Mili N et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143: 1121-1129
46. Knaus WA, Draper EA, Wagner DP et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
47. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006; 73: 503-508
48. Vilar J, Domingo ML, Soto C et al. Radiology of bacterial pneumonia. Eur J Radiol 2004; 51: 102-113
49. Gharib AM, Stern EJ. Radiology of pneumonia. Med Clin North Am 2001; 85: 1461-1491
50. Burrill J, Williams CJ, Bain G et al. Tuberculosis: a radiologic review. Radiographics 2007; 27: 1255-1273
51. Schiza S, Siafakas NM. Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr Opin Pulm Med 2006; 12: 205-211
52. Ott SR, Lode H. Diagnosis and therapy of aspiration pneumonia. Dtsch Med Wochenschr 2006; 131: 624-628
53. Levin DL. Radiology of pulmonary Mycobacterium avium-intracellulare complex. Clin Chest Med 2002; 23: 603-612
54. Datta D, Ali SA, Henken EM et al. Pneumocystis carinii pneumonia: the time course of clinical and radiographic improvement. Chest 2003; 124: 1820-1823
55. Tarver RD, Teague SD, Heitkamp DE et al. Radiology of community-acquired pneumonia. Radiol Clin North Am 2005; 43: 497-512, viii
56. Lawrence YR, Raveh D, Rudensky B et al. Extreme leukocytosis in the emergency department. Qjm 2007; 100: 217-223
57. Kroschinsky F, Schakel U, Ehninger G. Leucocytosis: Etiology and diagnostic approach. Internist (Berl) 2007; 48: 1239-1254
58. Williams WJ, Beutler E, Lichtman MA. Williams Hematology. New York: McGraw-Hill Medical Publishing Division, 2001
59. Kubic VL, Kubic PT, Brunning RD. The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. Am J Clin Pathol 1991; 95: 809-815
60. Almirall J, Bolibar I, Toran P et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004; 125: 1335-1342
61. Hansson LO, Hedlund JU, Ortqvist AB. Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. Scand J Clin Lab Invest 1997; 57: 111-118
62. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med 2006; 119: 166 e117-128
63. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30: 556-573
64. Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608
65. Tamaki K, Kogata Y, Sugiyama D et al. Diagnostic Accuracy of Serum Procalcitonin Concentrations for Detecting Systemic Bacterial Infection in Patients with Systemic Autoimmune Diseases. J Rheumatol 2008; 35: 114-119
66. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11: 473-480
67. Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607
68. Ramirez P, Garcia MA, Ferrer M et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008; 31: 356-362
69. Campbell SG, Marrie TJ, Anstey R et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123: 1142-1150
70. Weinstein MP, Reller LB, Murphy JR et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5: 35-53
71. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-1745
72. Bartlett JG. Decline in microbial studies for patients with pulmonary infections. Clin Infect Dis 2004; 39: 170-172
73. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004; 39: 165-169
74. Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20: 531-548
75. Gleckman R, DeVita J, Hibert D et al. Sputum gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 1988; 26: 846-849
76. Roson B, Carratala J, Verdaguer R et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-874
77. Ewig S, Torres A, Angeles Marcos M et al. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J 2002; 20: 1254-1262
78. Kalin M, Lindberg AA. Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis 1983; 15: 247-255
79. Reed WW, Byrd GS, Gates JrRH et al. Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis. West J Med 1996; 165: 197-204
80. Brightling CE. Clinical applications of induced sputum. Chest 2006; 129: 1344-1348
81. Pavord ID, Pizzichini MM, Pizzichini E et al. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52: 498-501
82. Warren JR, Bhattacharya M, De Almeida KN et al. A minimum 5.0 ml of sputum improves the sensitivity of acid-fast smear for Mycobacterium tuberculosis. Am J Respir Crit Care Med 2000; 161: 1559-1562
83. Mehta AC, Prakash UB, Garland R et al. American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. Chest 2005; 128: 1742-1755
84. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006; 130: 597-604
85. Dalhoff K, Marxsen J, Steinhoff J. Pneumonias and immunosuppression. Internist (Berl) 2007; 48: 507-508, 510-508
86. Narayanswami G, Salzman SH. Bronchoscopy in the human immunodeficiency virus-infected patient. Semin Respir Infect 2003; 18: 80-86
87. Baughman RP. Diagnosis of ventilator-associated pneumonia. Curr Opin Crit Care 2003; 9: 397-402
88. Baughman RP. Nonbronchoscopic evaluation of ventilator-associated pneumonia. Semin Respir Infect 2003; 18: 95-102
89. Brown KK. Chronic cough due to nonbronchiectatic suppurative airway disease (bronchiolitis): ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 132S-137S
90. Feller-Kopman D, Ernst A. The role of bronchoalveolar lavage in the immunocompromised host. Semin Respir Infect 2003; 18: 87-94
91. Salata RA, Lederman MM, Shlaes DM et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 135: 426-432
92. Rea-Neto A, Youssef NC, Tuche F et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 2008; 12: R56
93. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 2000; 117: 198S-202S
94. Glanville AR. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med 2006; 27: 480-491
95. Jafari C, Ernst M, Kalsdorf B et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 2006; 174: 1048-1054
96. Mattner F, Fischer S, Weissbrodt H et al. Post-operative nosocomial infections after lung and heart transplantation. J Heart Lung Transplant 2007; 26: 241-249
97. Cunningham R, Jenks P, Northwood J et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007; 65: 24-28
98. Rajan L, Smyth E, Humphreys H. Screening for MRSA in ICU patients. How does PCR compare with culture? J Infect 2007; 55: 353-357
99. Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127: 213-219
100. Roson B, Fernandez-Sabe N, Carratala J et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004; 38: 222-226
101. Murdoch DR, Laing RT, Cook JM. The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD. Clin Infect Dis 2003; 37: 153-154
102. Helbig JH, Uldum SA, Bernander S et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol 2003; 41: 838-840
103. Robert Koch-Institut. Zur Situation wichtiger Infektionskrankheiten in Deutschland: Legionellose im Jahr 2006. Epidemiologisches Bulletin, 2008: 50
104. Baum H von, Ewig S, Marre R et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008; 46: 1356-1364
105. Thorpe JE, Baughman RP, Frame PT et al. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987; 155: 855-861
106. Baker AM, Bowton DL, Haponik EF. Decision making in nosocomial pneumonia. An analytic approach to the interpretation of quantitative bronchoscopic cultures. Chest 1995; 107: 85-95
107. Fabregas N, Ewig S, Torres A et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54: 867-873
108. Schnoor M, Hedicke J, Dalhoff K et al. Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 2007; 55: 233-239
109. Baum H von, Ewig S, Marre R et al. Community acquired Legionella pneumonia. Clin Infect Dis (in press) 2008
110. Farr BM, Bartlett CL, Wadsworth J et al. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 2000; 94: 954-963
111. Loeb M, McGeer A, McArthur M et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159: 2058-2064
112. Schnoor M, Klante T, Beckmann M et al. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 2007; 135: 1389-1397
113. Baik I, Curhan GC, Rimm EB et al. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000; 160: 3082-3088
114. Fernandez-Sola J, Junque A, Estruch R et al. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995; 155: 1649-1654
115. Riquelme R, Torres A, El-Ebiary M et al. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 154: 1450-1455
116. Cook DJ, Walter SD, Cook RJ et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129: 433-440
117. Reinhart K, Brunkhorst F, Bone H et al. Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine. Internist (Berl) 2006; 47: 356-358-360, 362-358, passim
118. Monforte R, Estruch R, Vidal J et al. Delayed seroconversion in Legionnaire's disease. Lancet 1988; 2: 513
119. Schmidt-Ioanas M, Bender M, Roth A et al. Serologic early diagnosis of pneumonia caused by Mycoplasma pneumoniae. Dtsch Med Wochenschr 2006; 131: 613-617
120. Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 1999; 28 Suppl 2: S99-106
121. Konig CH von, Halperin S, Riffelmann M et al. Pertussis of adults and infants. Lancet Infect Dis 2002; 2: 744-750
122. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35: 2435-2443
123. Birkebaek NH. Bordetella pertussis in the aetiology of chronic cough in adults. Diagnostic methods and clinic. Dan Med Bull 2001; 48: 77-80
124. Heininger U. Pertussis: an old disease that is still with us. Curr Opin Infect Dis 2001; 14: 329-335
125. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38: 800-806